Oncotarget’s Top 10 Papers Published in 2023 (Crossref Data)
Oncotarget
Exploring Top 10 Oncotarget Papers of 2023 by Crossref
Exploring the significant research findings and advancements in oncology from the top 10 papers published in Oncotarget in 2023, encompassing diverse subjects like cancer prognosis, treatment approaches, and disease interactions.
00:00
Transcript
Play full episode
Transcript
Episode notes
Crossref is a non-profit organization that logs and updates citations for scientific publications. Each month, Crossref identifies a list of the most popular Oncotarget papers based on the number of times a DOI is successfully resolved.
Below are Crossref’s Top 10 Oncotarget DOIs published in 2023.
10: Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC)
DOI: https://doi.org/10.18632/oncotarget.28355
Authors: Md Maksudul Alam, Janmaris Marin Fermin, Mark Knackstedt, Mackenzie J. Noonan, Taylor Powell, Landon Goodreau, Emily K. Daniel, Xiaohua Rong, Tara Moore-Medlin, Alok R. Khandelwal, and Cherie-Ann O. Nathan
9: Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer
DOI: https://doi.org/10.18632/oncotarget.28353
Authors: Noriyuki Hirahara, Takeshi Matsubara, Shunsuke Kaji, Hikota Hayashi, Yohei Sasaki, Koki Kawakami, Ryoji Hyakudomi, Tetsu Yamamoto, and Yoshitsugu Tajima
8: Crosstalk between triple negative breast cancer and microenvironment
DOI: https://doi.org/10.18632/oncotarget.28397
Authors: Karly Smrekar, Artem Belyakov and Kideok Jin
7: Systemic AL amyloidosis: current approach and future direction
DOI: https://doi.org/10.18632/oncotarget.28415
Authors: Maroun Bou Zerdan, Lewis Nasr, Farhan Khalid, Sabine Allam, Youssef Bouferraa, Saba Batool, Muhammad Tayyeb, Shubham Adroja, Mahinbanu Mammadii, Faiz Anwer, Shahzad Raza, and Chakra P. Chaulagain
6: Deciphering the mechanisms of action of progesterone in breast cancer
DOI: https://doi.org/10.18632/oncotarget.28455
Authors: Gaurav Chakravorty, Suhail Ahmad, Mukul S. Godbole, Sudeep Gupta, Rajendra A. Badwe, and Amit Dutt
5: Targeting cellular respiration as a therapeutic strategy in glioblastoma
DOI: https://doi.org/10.18632/oncotarget.28424
Authors: Enyuan Shang, Trang Thi Thu Nguyen, Mike-Andrew Westhoff, Georg Karpel-Massler, and Markus D. Siegelin
4: Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells
DOI: https://doi.org/10.18632/oncotarget.28382
Author: Mikhail V. Blagosklonny, M.D., Ph.D.
3: The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy
DOI: https://doi.org/10.18632/oncotarget.28354
Authors: Anqi Shao and David M. Owens
2: Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss
DOI: https://doi.org/10.18632/oncotarget.28376
Authors: Maroun Bou Zerdan, Prashanth Ashok Kumar, Elio Haroun, Nimisha Srivastava, Jeffrey Ross, and Abirami Sivapiragasam
1: Using cancer proteomics data to identify gene candidates for therapeutic targeting
DOI: https://doi.org/10.18632/oncotarget.28420
Authors: Diana Monsivais, Sydney E. Parks, Darshan S. Chandrashekar, Sooryanarayana Varambally, and Chad J. Creighton
Oncotarget is an open-access, peer-reviewed journal that has published primarily oncology-focused research papers since 2010. These papers are available to readers (at no cost and free of subscription barriers) in a continuous publishing format at Oncotarget.com. Oncotarget is indexed/archived on MEDLINE / PMC / PubMed.
For media inquiries, please contact media@impactjournals.com.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
